ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļASPI
āļāļ·āđāļāļāļĢāļīāļĐāļąāļASP Isotopes Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļNov 10, 2022
āļāļĩāļāļĩāđāļAinscow (Robert)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ136
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļNov 10
āļāļĩāđāļāļĒāļđāđ601 Pennsylvania Avenue Nw
āđāļĄāļ·āļāļWASHINGTON
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ20004
āđāļāļĢāļĻāļąāļāļāđ12027562245
āđāļ§āđāļāđāļāļāđhttps://aspisotopes.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļASPI
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļNov 10, 2022
āļāļĩāļāļĩāđāļAinscow (Robert)
Mr. Paul Elliot Mann
Executive Chairman of the Board, Chief Executive Officer, Co-Founder
Executive Chairman of the Board, Chief Executive Officer, Co-Founder
Mr. Robert Ainscow
Co-Founder, Chief Operating Officer
Co-Founder, Chief Operating Officer
Ms. Heather Kiessling
Chief Financial Officer
Dr. Duncan Moore, Ph.D.
Independent Director
Dr. Todd Wider, M.D.
Independent Director
Prof. Michael (Mike) Gorley, Ph.D.
Prof. Michael (Mike) Gorley, Ph.D.
Independent Director
Mr. Sipho Nkosinathi Maseko
Mr. Sipho Nkosinathi Maseko
Independent Director
Dr. Hendrik Strydom, Ph.D.
Dr. Hendrik Strydom, Ph.D.
Chief Technology Officer
Mr. Robert Ryan
Independent Director
Mr. Jason Assad
Investor Relations
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Paul Elliot Mann
Executive Chairman of the Board, Chief Executive Officer, Co-Founder
Executive Chairman of the Board, Chief Executive Officer, Co-Founder
Mr. Robert Ainscow
Co-Founder, Chief Operating Officer
Co-Founder, Chief Operating Officer
Ms. Heather Kiessling
Chief Financial Officer
Dr. Duncan Moore, Ph.D.
Independent Director
Dr. Todd Wider, M.D.
Independent Director
Prof. Michael (Mike) Gorley, Ph.D.
Prof. Michael (Mike) Gorley, Ph.D.
Independent Director